Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deborah Schrag

Showing results (21-30 of 383) with videos related to

Pageof 39
Sort By:
JAMA|December 6, 2016
Biosimilar Therapy for ERBB2 (HER2)-Positive Breast Cancer: Close Enough?Harold J Burstein, Deborah Schrag
Journal of the National Cancer Institute|August 12, 2009
Challenges and opportunities for use of cost-effectiveness analysisK Robin Yabroff, Deborah Schrag
Journal of the National Cancer Institute|July 18, 2002
Attribution of deaths following cancer treatmentColin B Begg, Deborah Schrag
Journal of the National Cancer Institute|October 17, 2002
Risk charts: putting cancer in contextPeter B Bach, Deborah Schrag
JAMA|June 15, 2021
A Review of the Diagnosis and Treatment of Metastatic Colorectal Cancer-ReplyLeah H Biller, Deborah Schrag
JAMA|February 16, 2021
Diagnosis and Treatment of Metastatic Colorectal Cancer: A ReviewLeah H Biller, Deborah Schrag
American Journal of Epidemiology|April 22, 2020
Invited Commentary: Opportunities That Come With Studying the Co-Occurrence of Multiple OutcomesSebastien Haneuse, Deborah Schrag, Daniel Nevo
Statistics in Medicine|September 15, 2005
Using propensity scores to estimate the cost-effectiveness of medical therapiesAlka Indurkhya, Nandita Mitra, Deborah Schrag
JAMA|January 3, 2020
Adding Patient-Reported Outcomes to Medicare's Oncology Value-Based Payment ModelEthan Basch, Lalan Wilfong, Deborah Schrag
JAMA|November 9, 2021
Medicare Spending, Utilization, and Quality in the Oncology Care ModelRaymond U Osarogiagbon, Samyukta Mullangi, Deborah Schrag
Pageof 39

Showing results (21-30 of 383) with videos related to

Sort By:
Pageof 39
JAMA|December 6, 2016
Biosimilar Therapy for ERBB2 (HER2)-Positive Breast Cancer: Close Enough?Harold J Burstein, Deborah Schrag
Journal of the National Cancer Institute|August 12, 2009
Challenges and opportunities for use of cost-effectiveness analysisK Robin Yabroff, Deborah Schrag
Journal of the National Cancer Institute|July 18, 2002
Attribution of deaths following cancer treatmentColin B Begg, Deborah Schrag
Journal of the National Cancer Institute|October 17, 2002
Risk charts: putting cancer in contextPeter B Bach, Deborah Schrag
JAMA|June 15, 2021
A Review of the Diagnosis and Treatment of Metastatic Colorectal Cancer-ReplyLeah H Biller, Deborah Schrag
JAMA|February 16, 2021
Diagnosis and Treatment of Metastatic Colorectal Cancer: A ReviewLeah H Biller, Deborah Schrag
American Journal of Epidemiology|April 22, 2020
Invited Commentary: Opportunities That Come With Studying the Co-Occurrence of Multiple OutcomesSebastien Haneuse, Deborah Schrag, Daniel Nevo
Statistics in Medicine|September 15, 2005
Using propensity scores to estimate the cost-effectiveness of medical therapiesAlka Indurkhya, Nandita Mitra, Deborah Schrag
JAMA|January 3, 2020
Adding Patient-Reported Outcomes to Medicare's Oncology Value-Based Payment ModelEthan Basch, Lalan Wilfong, Deborah Schrag
JAMA|November 9, 2021
Medicare Spending, Utilization, and Quality in the Oncology Care ModelRaymond U Osarogiagbon, Samyukta Mullangi, Deborah Schrag
Pageof 39